| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.00022 | 1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.00016 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.00012 | 1 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 6.3e-05 | 1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 2.7e-05 | 1 |